05:06
Unknown
Ranbaxy on a PIL (Public Interest Litigation) seeking probe against the company for allegedly supplying adulterated drugs in the country. However, the SC has refused to pass an interim order to restrain the company from manufacturing drugs. This was the first time the pharma company has been penalised domestically.
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
Posted in: Indian Market Tips
0 comments:
Post a Comment